|
Chen, T J; Kuo, C B; Tsai, K F et al. (1998) Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 139:609-16
|
|
Liu, J W; Dawson, D D; Peters, C E et al. (1997) Estrogen replacement in ovariectomized rats results in physiologically significant levels of circulating progesterone, and co-administration of progesterone markedly reduces the circulating estrogen. Endocrine 6:125-31
|
|
Wang, Y F; Liu, J W; Mamidi, M et al. (1996) Identification of the major site of rat prolactin phosphorylation as serine 177. J Biol Chem 271:2462-9
|
|
Walker, A M; Montgomery, D W; Saraiya, S et al. (1995) Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc Natl Acad Sci U S A 92:3278-82
|
|
Krown, K A; Wang, Y F; Walker, A M (1994) Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology 134:1546-52
|
|
Wang, Y F; Walker, A M (1993) Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between nonphosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 133:2156-60
|
